IQE plc
("IQE" or the "Company")
Directors Share Purchases and Finance Facility
14 October 2014
IQE plc (IQE or the' Company'), the leading supplier of Advanced Semiconductors Wafer products to the Global Semiconductor market, has received notification from the Executive Directors that they have purchased a total of 3.3 million ordinary shares in IQE plc at 12.75p per share.
In order to fund the purchase of the shares and to satisfy income tax obligations following the exercise of share options announced on the 10th October, the Directors have entered into loan agreements and have transferred a total of 18 million existing shares as security. The Directors are required to redeem the transferred shares at maturity when the loan is repaid at the end of the three year term. Under the terms of the facility, the lender is prohibited from short selling or voting the shares during the term of the loan. The loan facility has been arranged , and the funding provided, by Equities First Holdings, a securities based capital provider of finance for private and institutional investors.
Following these purchases, the executive directors have the following interests in the equity of the company
Name | No. of Ordinary Shares prior to option exercise | Option Exercise | No. of Ordinary Shares purchased | No. of Ordinary Shares after exercise and purchase | Ordinary Shares as a % of ISC |
Dr. Drew Nelson, CEO | 28,658,465 | 4,800,753 | 1,800,000 | 35,259,218 | 5.36% |
Phillip Rasmussen, CFO | 852,822 | 1,870,535 | 750,000 | 3,473,357 | 0.53% |
Dr. Howard Williams, COO | 1,672,430 | 1,870,535 | 750,000 | 4,292,965 | 0.65% |
Total number of shares in issue is 658,134,599
Contacts:
IQE plc +44 (0) 29 2083 9400
Drew Nelson
Phil Rasmussen
Chris Meadows
Canaccord Genuity + 44 (0) 20 7523 8000
Simon Bridges
Cameron Duncan
Peel Hunt +44 (0) 20 7418 8900
Andy Crossley
Richard Kauffer